News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
101 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (22766)
Month
January (2433)
February (2868)
March (3029)
April (3116)
May (3356)
June (2727)
July (2287)
August (2493)
September (457)
Day
1 (180)
2 (176)
3 (101)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
Day
1
2
3
FDA
Replimune’s melanoma drug would have been rejected again if not for senior CBER official
The FDA’s primary review team found that Replimune hadn’t sufficiently addressed deficiencies that had been pointed out in the two prior rejection letters for the melanoma therapy Tudriqev.
September 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
September 3, 2026
·
1 min read
Press Releases
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 3, 2026
September 3, 2026
·
1 min read
Press Releases
BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
·
2 min read
Press Releases
Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
·
2 min read
Press Releases
Avalo Therapeutics to Participate in Upcoming September 2026 Investor Conferences
September 3, 2026
·
1 min read
Press Releases
Cartesian Therapeutics to Participate in Upcoming September 2026 Investor Conferences
September 3, 2026
·
1 min read
Press Releases
Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
·
2 min read
Press Releases
Climb Bio Announces CLYM116 Phase 1 Data Demonstrating Prolonged Half-Life and Best-In-Class APRIL Suppression Supporting Every-12-Week Dosing in IgA Nephropathy
September 3, 2026
·
7 min read
Press Releases
LeonaBio to Participate in Cantor Global Healthcare Conference 2026
September 3, 2026
·
1 min read
Previous
3 of 11
Next
